congress
presentations

ESRS 2024

Seville, Spain
September 24-27, 2024

PDF screenshot

AXS-12 | Narcolepsy

AXS-12 for the Treatment of Narcolepsy: Topline Results From the Phase 3 SYMPHONY Trial

view/download

PDF screenshot

AXS-12 | Narcolepsy

CRESCENDO: Results from a Survey of Symptom Burden and Quality of Life in Patients with Narcolepsy Type 1

view/download

PDF screenshot

Solriamfetol | Excessive Daytime Sleepiness

Solriamfetol and Maintenance of Wakefulness Outcomes in Patients With Narcolepsy and Obstructive Sleep Apnea

view/download

PDF screenshot

Solriamfetol | Excessive Daytime Sleepiness

Plenary Presentation: Solriamfetol and Maintenance of Wakefulness Outcomes in Patients With Narcolepsy and Obstructive Sleep Apnea

view/download

PDF screenshot

Solriamfetol | Excessive Daytime Sleepiness

Effects of Solriamfetol on Cognition in Patients With Excessive Daytime Sleepiness Associated With Narcolepsy

view/download

PDF screenshot

Solriamfetol | Excessive Daytime Sleepiness

Real-world Use of Solriamfetol for Excessive Daytime Sleepiness in Patients Reporting Anxiety or Depression

view/download

PDF screenshot

Solriamfetol | Excessive Daytime Sleepiness

SURWEY: Treatment of Excessive Daytime Sleepiness With Solriamfetol: Initiation, Titration, and Outcomes

view/download

PDF screenshot

Solriamfetol | Excessive Daytime Sleepiness

Effects of Solriamfetol on Cognition in Obstructive Sleep Apnea With Excessive Daytime Sleepiness and Impaired Cognition

view/download

This site is intended for registered attendees of the respective Congress.
This site contains scientific presentations on investigational products and/or investigational uses of approved products for Axsome or its partners sponsored studies.
The safety and efficacy of investigational products and/or investigational uses of approved products has not been established and such investigational products/uses have not and may not be approved for marketing by any health authority.
Marketing authorization, approval status, and prescribing information for approved products varies by country. Please seek further details from the health authority in your country such as approved product labeling.

AXSOME and its logos are trademarks or registered trademarks of Axsome Therapeutics, Inc. or its affiliates. Other trademarks are property of their respective owners.

© 2023 Axsome Therapeutics, Inc. All rights reserved. One World Trade Center, 22nd Floor, New York, NY 10007 info@axsome.com